Expression and prognostic value of MCM2 in type B thymomas
MCM2 is an independent prognostic factor for TETs, with higher expression linked to better PFS and decreasing expression across B-type thymomas, suggesting its role as a favorable prognostic marker.
Authors
- Xintao Yu
- Dingfang Cao
- Jian Cui (ORCID: https://orcid.org/0000-0001-7677-9522)
- Xin Du
- Ying Zhang (ORCID: https://orcid.org/0000-0002-8531-1291)
- Shanqing Li (ORCID: https://orcid.org/0000-0002-5602-9393)
- Lei Yu
Institutions
- Beijing Tongren Hospital (CN)
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1186/s12885-025-14807-4
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Peking Union Medical College Hospital
- Beijing Association for Science and Technology